{"gao_id": "GAO-05-102", "published": "2005-02-04T12:02:00Z", "released": "2005-03-07T07:03:00Z", "summary": "", "title": "Medicaid Drug Rebate Program: Inadequate Oversight Raises Concerns about Rebates Paid to States", "topics": ["Health insurance", "Manufacturing industry", "Data integrity", "Pharmaceutical industry", "Prices and pricing", "Drugs", "Medicaid", "Rebates", "Prescription drugs", "Health Care", "Health care cost control"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-05-102", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-05-102-highlights.pdf"}, {"title": "Full Report (37 pages)", "url": "https://www.gao.gov/assets/gao-05-102.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a245260.html"}]}